[Psoriasis and day hospital. Clinical and therapeutic considerations concerning 104 cases].
One hundred and four patients with psoriasis, treated in regimen of Day Hospital, have been examined. The diagnosis was widespread plaque type psoriasis (67.3%), guttate psoriasis (18.3%) and nail psoriasis (1.0%). Furthermore psoriatic erythroderma has been observed in 2.9% and pustular psoriasis of Barber in 1.9%. 10% of the patients showed psoriatic arthritis. 71.2% of the patients have been successfully treated with UVB and PUVA irradiation therapy (respectively 86.6% and 70.0% of complete clearing or marked improvement). Etretinate and topical therapy were successful (respectively 67.0% and 70.0% of complete clearing or marked improvement). Day Hospital has proved to be the ideal regimen for the treatment and control of psoriatic patients.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001557:Benzenesulfonates; D002648:Child; D002675:Child, Preschool; D003033:Coal Tar / Q000008:administration & dosage; D003631:Day Care, Medical; D005050:Etretinate / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011701:PUVA Therapy; D011565:Psoriasis / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D012459:Salicylates / Q000008:administration & dosage; D014467:Ultraviolet Therapy
D000893:Anti-Inflammatory Agents; D001557:Benzenesulfonates; D005938:Glucocorticoids; D009824:Ointments; D012459:Salicylates; D005050:Etretinate; D003033:Coal Tar; C003366:sulfosalicylic acid
Psoriasi e Day Hospital. Considerazioni cliniche e terapeutiche su 104 casi.